HF
BNTC icon

HRT Financial’s Benitec Biopharma BNTC Stock Holding History

HRT Financial’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,288
Closed -$178K – 3830
2025
Q4 		$178K Buy
+13,288
New +$184K ﹤0.01% 2663
2025
Q2 		– Sell
-25,927
Closed -$337K – 2656
2025
Q1 		$337K Buy
+25,927
New +$314K ﹤0.01% 1711
2023
Q1 		– Sell
-675
Closed -$1K – 2520
2022
Q4 		$1K Buy
+675
New +$2.29K ﹤0.01% 2369

Other funds holding BNTC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

HRT Financial's BNTC Position: Q1 2026 in Review

HRT Financial sold out of Benitec Biopharma (BNTC) in Q1 2026, closing a stake of 13,288 shares — an estimated $178K sold.

HRT Financial first reported a position in BNTC in Q4 2022 and held it in 3 quarters. The position peaked at $337K in Q1 2025. 88 funds tracked by Wall St. Rank hold BNTC as of Q1 2026.

  • HRT Financial reported no remaining Benitec Biopharma position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 13,288 Benitec Biopharma shares in Q1 2026, an estimated $178K.
  • HRT Financial first reported a position in Benitec Biopharma in Q4 2022 and held it in 3 quarters.
  • HRT Financial's Benitec Biopharma position peaked at $337K in Q1 2025.
  • 88 funds tracked by Wall St. Rank held Benitec Biopharma as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.